Vitamin D Reduces Diabetes Risk in Specific Genetic Subgroups

A recent study indicates that daily vitamin D supplementation may reduce the risk of developing type 2 diabetes by 19% in individuals with prediabetes who possess specific genetic variations. This effect was observed in participants with the AC or CC variants of the Apal vitamin D receptor gene.

Conversely, individuals with the AA variant of the same gene did not exhibit a similar reduction in diabetes risk when taking vitamin D supplements. This suggests a gene-specific response to vitamin D intervention.

These findings, if confirmed, could lead to more targeted preventative strategies for type 2 diabetes. The research highlights the potential for precision medicine approaches based on genetic profiling to optimize treatment efficacy and patient outcomes.

However, the study also notes that high vitamin D levels required for this effect might increase the risk of falls in older adults. This necessitates a careful assessment of risks and benefits for individual patients before implementing high-dose vitamin D regimens.